ABBOTT LABORATORIES (ABT) Fundamental Analysis & Valuation
NYSE:ABT • US0028241000
Current stock price
105.46 USD
-1.73 (-1.61%)
At close:
106.368 USD
+0.91 (+0.86%)
After Hours:
This ABT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABT Profitability Analysis
1.1 Basic Checks
- ABT had positive earnings in the past year.
- In the past year ABT had a positive cash flow from operations.
- ABT had positive earnings in each of the past 5 years.
- In the past 5 years ABT always reported a positive cash flow from operatings.
1.2 Ratios
- ABT has a Return On Assets of 7.52%. This is amongst the best in the industry. ABT outperforms 87.77% of its industry peers.
- The Return On Equity of ABT (12.51%) is better than 88.30% of its industry peers.
- The Return On Invested Capital of ABT (9.17%) is better than 87.77% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ABT is in line with the industry average of 9.28%.
- The last Return On Invested Capital (9.17%) for ABT is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- The Profit Margin of ABT (14.72%) is better than 90.96% of its industry peers.
- ABT's Profit Margin has improved in the last couple of years.
- With an excellent Operating Margin value of 18.85%, ABT belongs to the best of the industry, outperforming 90.43% of the companies in the same industry.
- ABT's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 56.68%, ABT is in line with its industry, outperforming 57.45% of the companies in the same industry.
- ABT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABT Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABT is destroying value.
- ABT has more shares outstanding than it did 1 year ago.
- ABT has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for ABT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 4.94 indicates that ABT is not in any danger for bankruptcy at the moment.
- Looking at the Altman-Z score, with a value of 4.94, ABT is in the better half of the industry, outperforming 78.72% of the companies in the same industry.
- ABT has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
- ABT's Debt to FCF ratio of 1.75 is amongst the best of the industry. ABT outperforms 87.77% of its industry peers.
- A Debt/Equity ratio of 0.19 indicates that ABT is not too dependend on debt financing.
- ABT's Debt to Equity ratio of 0.19 is in line compared to the rest of the industry. ABT outperforms 58.51% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.94 |
ROIC/WACC0.91
WACC10.1%
2.3 Liquidity
- A Current Ratio of 1.58 indicates that ABT should not have too much problems paying its short term obligations.
- ABT's Current ratio of 1.58 is on the low side compared to the rest of the industry. ABT is outperformed by 73.40% of its industry peers.
- ABT has a Quick Ratio of 1.18. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- ABT's Quick ratio of 1.18 is on the low side compared to the rest of the industry. ABT is outperformed by 69.68% of its industry peers.
- The current and quick ratio evaluation for ABT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABT Growth Analysis
3.1 Past
- ABT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- ABT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- ABT shows a small growth in Revenue. In the last year, the Revenue has grown by 5.67%.
- Measured over the past years, ABT shows a small growth in Revenue. The Revenue has been growing by 5.08% on average per year.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
- ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABT Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 20.48 indicates a rather expensive valuation of ABT.
- 79.79% of the companies in the same industry are more expensive than ABT, based on the Price/Earnings ratio.
- The average S&P500 Price/Earnings ratio is at 25.23. ABT is around the same levels.
- A Price/Forward Earnings ratio of 18.36 indicates a rather expensive valuation of ABT.
- ABT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 81.91% of the companies in the same industry.
- Compared to an average S&P500 Price/Forward Earnings ratio of 22.42, ABT is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.48 | ||
| Fwd PE | 18.36 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, ABT is valued a bit cheaper than the industry average as 77.13% of the companies are valued more expensively.
- ABT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ABT is cheaper than 81.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.78 | ||
| EV/EBITDA | 16.29 |
4.3 Compensation for Growth
- ABT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ABT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.78
PEG (5Y)2.87
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABT Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.35%, ABT has a reasonable but not impressive dividend return.
- ABT's Dividend Yield is rather good when compared to the industry average which is at 0.24. ABT pays more dividend than 96.28% of the companies in the same industry.
- ABT's Dividend Yield is a higher than the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.35% |
5.2 History
- On average, the dividend of ABT grows each year by 10.37%, which is quite nice.
- ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
- ABT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.37%
Div Incr Years34
Div Non Decr Years34
5.3 Sustainability
- 63.09% of the earnings are spent on dividend by ABT. This is not a sustainable payout ratio.
- ABT's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABT Fundamentals: All Metrics, Ratios and Statistics
105.46
-1.73 (-1.61%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner Change3.65%
Ins Owners0.47%
Ins Owner Change1.11%
Market Cap183.25B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80
Price Target136.02 (28.98%)
Short Float %1.06%
Short Ratio1.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.35% |
Yearly Dividend2.37
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years34
Div Non Decr Years34
Ex-Date04-15 2026-04-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-7.35%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.33%
EPS NY rev (1m)0.03%
EPS NY rev (3m)0.2%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)-0.02%
Revenue NY rev (3m)-0.91%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.48 | ||
| Fwd PE | 18.36 | ||
| P/S | 4.13 | ||
| P/FCF | 24.78 | ||
| P/OCF | 19.16 | ||
| P/B | 3.52 | ||
| P/tB | 8.12 | ||
| EV/EBITDA | 16.29 |
EPS(TTM)5.15
EY4.88%
EPS(NY)5.74
Fwd EY5.45%
FCF(TTM)4.26
FCFY4.04%
OCF(TTM)5.51
OCFY5.22%
SpS25.51
BVpS30
TBVpS12.99
PEG (NY)1.78
PEG (5Y)2.87
Graham Number58.96
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.94 |
F-Score6
WACC10.1%
ROIC/WACC0.91
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year6.97%
Revenue Next 2Y7.18%
Revenue Next 3Y7.13%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABT Fundamental Analysis FAQ
What is the fundamental rating for ABT stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABT.
What is the valuation status of ABBOTT LABORATORIES (ABT) stock?
ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
What is the profitability of ABT stock?
ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 20.48 and the Price/Book (PB) ratio is 3.52.
Can you provide the expected EPS growth for ABT stock?
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.53% in the next year.